The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. Hermann Einsele | ASH 2017 | Rationale for combining HDAC inhibitor and daratumumab

Dec 21, 2017

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA

Professor Hermann Einsele

 

Rationale for combining HDAC inhibitor and daratumumab